Showing results (21-30 of 396) with videos related to
Sort By:
Pageof 40
Frontiers in Immunology|January 13, 2018
Harnessing the Power of Invariant Natural Killer T Cells in Cancer ImmunotherapyMelissa Bedard, Mariolina Salio, Vincenzo CerundoloTransplantation|April 28, 2006
Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsiesIsabel Quiroga, Mariolina Salio, Dicken D H Koo, et al.Current Opinion in Immunology|May 18, 2010
Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balanceVincenzo Cerundolo, Patricia Barral, Facundo D BatistaThe Veterinary Record|January 25, 2019
Incidence of anti-Der f 2 and anti-Zen 1-specific immunoglobulin E antibodies in atopic dogs from South-East EnglandAnita Patel, Cathy F Curtis, Rosario CerundoloNature Reviews. Immunology|May 11, 2002
Tracking T cells with tetramers: new tales from new toolsPaul Klenerman, Vincenzo Cerundolo, P Rod DunbarCurrent Opinion in Immunology|August 25, 2019
Capturing the antigen landscape: HLA-E, CD1 and MR1Graham Ogg, Vincenzo Cerundolo, Andrew J McMichaelFrontiers in Immunology|July 3, 2015
MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious DiseasesLauren J Howson, Mariolina Salio, Vincenzo CerundoloCurrent Opinion in Immunology|January 19, 2010
Recent advances in processing and presentation of CD1 bound lipid antigensMariolina Salio, Jonathan D Silk, Vincenzo CerundoloImmunotherapy|December 22, 2016
Modulation of cancer-specific immune responses by amino acid degrading enzymesElina Timosenko, Andreas V Hadjinicolaou, Vincenzo CerundoloJournal of Immunotherapy (Hagerstown, Md. : 1997)|June 28, 2012
Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunitiesFrancis Mussai, Carmela De Santo, Vincenzo CerundoloPageof 40